References
- Kantarjian H. M., Keating M. J., Walters R. S. Therapy related leukemia and myelodysplastic syndrome: Clinical cytogenetic and prognostic features. J. Clin. Oncol 1986; 12: 1748–1757
- Michels S. D., McKenna R., Arthur D. C., Brunning R. D. Therapy related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphological study of 65 cases. Blood 1985; 65: 1364–1372, 1985.
- Pedersen-Bjergaard J., Philip P., Larsen S., Jensen G., Byroting K. Chromosome aberrations and prognostic factors in therapy related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 16: 1083–1091
- Levine E. G., Bloomfield C. D. Secondary myelodysplastic syndromes and leukemias. Cancer Genet Cytogenet 1986; 4: 1037–1080
- Groupe Français de Cytogénétique hématologique. Chromosome analysis of 63 cases of secondary non lymphoid blood disorders. A cooperative study. Cancer Genet Cytogenet; 1984; 12: 95–104
- Bloomfield C. D. Chromosome abnormalities in secondary myelodysplastic syndromes. Scand J Haematol 1986; 36: 82–90, (suppl).
- Kantarjian H. M., Keating M., Walters R. The association of specific “favorable” cytogenetic abnormalities with secondary leukemia. Cancer; 1986; 58: 924–927
- Heim S., Mitelman F. Secondary chromosome aberrations in the acute leukemias. Cancer Genet Cytogenet; 1986; 22: 331–338
- Larson R. A., Williams S. F., Le Beau M. M., Bitter M. A., Vardiman J. W., Rowley J. D. Acute myelomonocytic leukemia with abnormal cosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood; 1986; 68: 1242–1249
- Fenaux P., Lucidarme D., Lai J. L., Bauters F. Favorable cytogenetic abnormalities in secondary leukemia. Cancer 1989; 63: 2505–2508
- ISCN. An international system for human cytogenetic nomenclature. Cytogenet Cell Genet; 1978; 21: 309–404
- Bennett J., Catovsky D., Daniel M. T. Proposals for the classification of acute leukemias. Br. J Haematol; 1976; 33: 451–458
- Bennett J., Catovsky D., Daniel M. T. Proposals for the classification of myelodysplastic syndromes. Br. J. Haematol; 1982; 51: 189–199
- Pui C., Behm F., Raimondi S. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321: 135–142
- De Vore R., Whiteleck J., Hainsworth J., Johnson D. Therapy related acute nonlymphocytic leukemia with monocytic features and rearrangements of chromosome 11q. Ann. Int Med 1989; 110: 740–742
- Pedersen-Bjergaard J., Philip P., Raun V., Hansen S. W., Nissen N. I. Therapy related acute non lymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11)(p21;q23) or normal karyotype: A separate entity?. J Clin Oncol; 1988; 6: 395–397
- Schiffer C. A., Lee E. J., Tomiyasu T., Wiernik P. H., Reck K., Testa R. The prognostic impact of cytogenetic abnormalities in patients with de novo acute non-lymphocytic leukemia (Abstr). Blood 1984; 70: 208a, (suppl)
- Fenaux P., Preudhomme C., Lai J. L. Cytogenetics and their prognostic value in de novo ANLL: a report on 283 cases. Br J Haematol 1989; 73: 61–67
- Kalwinsky D., Raimondi S., Schell M. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin One 1990; 8: 75–83
- Heim S., Mitelman F. Chromosomal abnormalities in myelodysplastic syndrome. Clin Haematol 1986; 15: 1003–1021
- Knapp R. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Maya Clin Proc 1985; 60: 507–5123
- Cheson B. The myelodysplastic syndromes: current approaches to therapy. Ann Int Med 1990; 112: 932–941, 1990.
- Fenaux P., Morel P., Lai J. L., Jouet J. P., Haulers F. Prognostic factors in de novo myelodysplastic syndromes treated by intensive chemotherapy: a report on 47 cases, (submitted to publication)
- Grünwald H. W., Rosner F. Acute leukemia and immunosuppressive drug use: A review of patients undergoing immunosuppressive therapy for non-neoplastic disorders. Arch Intern Med 1983; 139: 461–466